BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 18777847)

  • 1. [When should we start the treatment of the cardiovascular risk factors].
    de Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2008; 125(1):125-36; discussion 136-44. PubMed ID: 18777847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A practical approach to reducing cardiovascular risk factors.
    Fonarow GC
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S25-36. PubMed ID: 17934391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes as a 'cardiovascular disease equivalent': implications for treatment.
    Laakso M
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):682-3. PubMed ID: 18797431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
    Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen ML; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ;
    Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():E1-40. PubMed ID: 17726406
    [No Abstract]   [Full Text] [Related]  

  • 7. [Implementation of clinical guidelines in general practice. The effect of journal audit and continuing education for the treatment of cardiovascular risk factors in patients with and without type 2 diabetes].
    Madsbad S; Larsen ML; Adeler HF; Kryhlmand M; Westergaard M
    Ugeskr Laeger; 2006 Apr; 168(17):1640-5. PubMed ID: 16674875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stroke--primary prophylaxis].
    Russell D; Dahl A; Lund C
    Tidsskr Nor Laegeforen; 2007 Mar; 127(6):754-8. PubMed ID: 17363990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood risk factors for adult cardiovascular disease and primary prevention in childhood.
    Celermajer DS; Ayer JG
    Heart; 2006 Nov; 92(11):1701-6. PubMed ID: 17041125
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary prevention of cardiovascular disease].
    Gohlke H
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factor management: a practice guide.
    Perk J
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S24-8. PubMed ID: 19675433
    [No Abstract]   [Full Text] [Related]  

  • 12. [How to defuse the diabetes mellitus time bomb: identify early signs and vascular injuries, minimize risk factors].
    Janka HU
    MMW Fortschr Med; 2003 May; 145(21):29-30. PubMed ID: 12845863
    [No Abstract]   [Full Text] [Related]  

  • 13. [Guidelines for the management of atherosclerotic diseases in diabetes mellitus].
    Kotake H; Oikawa S
    Nihon Rinsho; 2006 Nov; 64(11):2074-80. PubMed ID: 17087299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physical activity in basic and primary prevention of cardiovascular disease].
    Sobieszczańska M; Kałka D; Pilecki W; Adamus J
    Pol Merkur Lekarski; 2009 Jun; 26(156):659-64. PubMed ID: 19711738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution of cardiovascular risk factors in coronary patients in Sahel, Tunisia].
    Lihioui M; Boughzala E; Ben Farhat M; Ammar H; Chaouech A; Jemaa R; Kaabachi N
    East Mediterr Health J; 2007; 13(3):536-43. PubMed ID: 17687825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time for results: a better way to reduce cardiovascular risk.
    Mola A; Lloyd M
    Adv Nurse Pract; 2002 Apr; 10(4):34-41; quiz 42-3. PubMed ID: 12418348
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing multiple cardiovascular risk factors.
    Blank RC; Brunton S
    J Fam Pract; 2008 Mar; 57(3 Suppl Managing):S13-20. PubMed ID: 18664333
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of coronary disease in clinical practice. Guidelines of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyorala K; De Backer G; Graham I; Poole-wilson P; Wood D
    G Ital Cardiol; 1996 Feb; 26(2):127-68. PubMed ID: 8666173
    [No Abstract]   [Full Text] [Related]  

  • 19. The effectiveness of walking in preventing cardiovascular disease in women: a review of the current literature.
    Albright C; Thompson DL
    J Womens Health (Larchmt); 2006 Apr; 15(3):271-80. PubMed ID: 16620186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for common clinical conditions in older women.
    Thakur SS; Supiano MA
    Clin Obstet Gynecol; 2007 Sep; 50(3):767-75. PubMed ID: 17762424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.